Company Monitoring Page for Allergan

latest headlines for company on cafepharma

States Push Ahead With Investigation Into Opioid Painkillers
FOX Business
Tue, 09/19/17 - 10:41 pm
Tags:
opioids, opioid crisis, Endo International, Janssen, Allergan, Teva Pharmaceutical, Purdue Pharma
This pharma CEO won praise for his ‘social contract’ with the public. But his latest move could shred that pledge
Stat
Tue, 09/19/17 - 09:26 am
Tags:
Pharma CEOs, Allergan, Brent Saunders, drug pricing, Restasis
FDA commish cheers on biosimilars as Amgen, Allergan score OK for knockoff of Roche’s Avastin
Endpoints
Fri, 09/15/17 - 09:14 am
Tags:
FDA, Scott Gottlieb, Amgen, Allergan, biosimilars, Mvasi, Roche, Avastin
Mylan attacks Allergan over its Mohawk-allied patent strategy — but the CEO is sticking to his guns
Endpoints
Wed, 09/13/17 - 10:35 am
Tags:
Allergan, Mylan Labs, patents, Brent Saunders
Allergan's Patent Loophole Could Be a Huge Gift for Pfizer
Motley Fool
Mon, 09/11/17 - 09:54 am
Tags:
Allergan, patents, Restasis, Pfizer
Allergan CEO gambles a multibillion-dollar franchise — and his company rep — on a high-stakes bet at an Indian casino op
Endpoints
Sat, 09/9/17 - 01:21 pm
Tags:
Allergan, Pharma CEOs, Brent Saunders, Restasis, patents
Allergan-Restasis Patent Battle Could Test Lawmakers' Resolve
NY Shock Exchange
Wed, 09/6/17 - 09:11 am
Tags:
Allergan, Restasis, patents, Mylan Labs, Pfizer, Teva Pharmaceutical, Shire
Key FDA Regulatory Events to Watch Out for in Sep 2017
Yahoo/Zacks.com
Mon, 09/4/17 - 10:31 pm
Tags:
FDA, Mylan Labs, Herceptin, biosimilars, trastuzumab, Shingrix, GSK, Pfizer, Sutent, PTC Therapeutics, Translarna, Amgen, Allergan, Avastin
Allergan heads to federal court to defend Restasis against early generic rivals
Fierce Pharma
Tue, 08/29/17 - 09:14 pm
Tags:
Allergan, Restasis, generics, Mylan Labs, Teva Pharmaceutical, Akorn, InnoPharma
Allergan hits its already battered Irvine site with another round of job cuts
Fierce Pharma
Tue, 08/29/17 - 09:11 pm
Tags:
Allergan, layoffs, R&D
Has the Brent Saunders price-hike limit become a de facto pharma rule?
Fierce Pharma
Mon, 08/14/17 - 11:01 am
Tags:
Brent Saunders, Allergan, drug pricing
Allergan's Brent Saunders Is Charging Into Medical Aesthetics. Should Others Follow?
Forbes
Tue, 08/8/17 - 11:20 am
Tags:
Allergan, Brent Saunders, aesthetics, Pharma CEOs
FDA approves 4-year intrauterine device
Drug Delivery Business News
Mon, 08/7/17 - 05:58 pm
Tags:
FDA, Allergan, IUD, devices, contraceptives, Liletta
Allergan ramps up promotion for new rosacea drug
Medical Marketing and Media
Mon, 08/7/17 - 11:29 am
Tags:
Allergan, Rosacea, Rhofade, CVS Health
Pfizer's Poor Earnings Feed the Allergan Tie-Up Fire
TheStreet.com
Sun, 08/6/17 - 09:50 pm
Tags:
Pfizer, earnings, Allergan, M&A
Botox, fillers steal the show as Allergan posts Q2 beats
Fierce Pharma
Thu, 08/3/17 - 09:50 pm
Tags:
Allergan, earnings
As Roche wades biosimilar waters, more competitors circle Herceptin
BioPharma Dive
Wed, 08/2/17 - 09:28 pm
Tags:
Roche, Herceptin, biosimilars, Amgen, Allergan, ABP 980, Celltrion, CT-P6
Allergan can finally sell its losing stake in Teva. Will it?
Fierce Pharma
Wed, 08/2/17 - 09:26 pm
Tags:
Allergan, Teva Pharmaceutical
FDA advances two more Herceptin biosims—this time from Amgen and Teva—as Roche braces for impact
Fierce Pharma
Mon, 07/31/17 - 09:56 pm
Tags:
FDA, Herceptin, biosimilars, Roche, Amgen, Teva Pharmaceutical, Allergan, Celltrion
Allergan CEO comes out against aesthetic treatments for teens in debate-sparking blog post
Fierce Pharma
Wed, 07/12/17 - 02:43 pm
Tags:
Allergan, Pharma CEOs, aesthetics, Brent Saunders

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.